- Home
- UNCY vs MSSA Comparison
UNCY vs MSSA Comparison
Compare UNCY & MSSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- MSSA
- Stock Information
- Founded
- UNCY 2016
- MSSA 2021
- Country
- UNCY United States
- MSSA United States
- Employees
- UNCY N/A
- MSSA N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- MSSA
- Sector
- UNCY Health Care
- MSSA
- Exchange
- UNCY Nasdaq
- MSSA NYSE
- Market Cap
- UNCY 58.7M
- MSSA N/A
- IPO Year
- UNCY 2021
- MSSA 2022
- Fundamental
- Price
- UNCY $0.59
- MSSA $12.80
- Analyst Decision
- UNCY Strong Buy
- MSSA
- Analyst Count
- UNCY 3
- MSSA 0
- Target Price
- UNCY $6.50
- MSSA N/A
- AVG Volume (30 Days)
- UNCY 1.0M
- MSSA 487.0
- Earning Date
- UNCY 05-12-2025
- MSSA 01-01-0001
- Dividend Yield
- UNCY N/A
- MSSA N/A
- EPS Growth
- UNCY N/A
- MSSA N/A
- EPS
- UNCY N/A
- MSSA N/A
- Revenue
- UNCY N/A
- MSSA N/A
- Revenue This Year
- UNCY N/A
- MSSA N/A
- Revenue Next Year
- UNCY $888.72
- MSSA N/A
- P/E Ratio
- UNCY N/A
- MSSA $88.84
- Revenue Growth
- UNCY N/A
- MSSA N/A
- 52 Week Low
- UNCY $0.20
- MSSA $11.10
- 52 Week High
- UNCY $1.60
- MSSA $14.48
- Technical
- Relative Strength Index (RSI)
- UNCY 49.08
- MSSA 88.42
- Support Level
- UNCY $0.53
- MSSA $12.08
- Resistance Level
- UNCY $0.64
- MSSA $13.50
- Average True Range (ATR)
- UNCY 0.06
- MSSA 0.07
- MACD
- UNCY -0.01
- MSSA 0.06
- Stochastic Oscillator
- UNCY 35.62
- MSSA 53.33
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.